# Hepatitis Viruses for NEET PG Microbiology: HAV, HBV Serology, HCV, HDV and HEV, With India's HBV Birth-Dose and Pregnancy Screening

Source: https://tracknation.in/story/hepatitis-viruses-for-neet-pg-microbiology-hav-hbv-serology-hcv-hdv-and-hev-with-india-s-hbv-birth-dose-and-pregnancy-screening (TrackNation — free UPSC notes with PYQs)

> NEET PG Microbiology: hepatitis A to E — genome, spread and chronicity, HBV serological markers and the window period, chronicity by age, HCC risk, HCV genotypes and cure, HDV coinfection vs superinfection, HEV in pregnancy, and India's HBsAg screening and HBIG + birth-dose policy, with a diagram, hooks, MCQs and cards.

## Start Here

🎯 **Exam priority: Very high.** *Expect: which hepatitis viruses are faecal–oral and which become chronic, HBV markers (HBsAg,
IgM anti-HBc, anti-HBs, HBeAg) and the window period, chronicity by age at infection, HCC with or without cirrhosis, HCV genotypes and DAAs, HDV
coinfection vs superinfection, HEV in pregnancy and pigs, and India's HBsAg screening, HBIG and birth-dose rules.*

CBME mapping: **MI4.7–4.8**. Fact-checked against the MSD Manual, the NACO EVTHS guidelines (2024) and the MoHFW UIP (2026).

*Hepatitis A–E, HBV serology, HCV and Indian prevention. Drawn by TrackNation.*

## Hepatitis A and E: Faecal–Oral (MSD)

- **HAV** and **HEV** spread **faecal–orally**; hepatitis B and C predispose to chronic hepatitis and liver cancer, hepatitis A
does not.

- **HAV**: enterically transmitted **RNA** virus; young children often asymptomatic; **no chronic carrier state**, no
cirrhosis. **IgM anti-HAV** = acute infection; total anti-HAV = immunity. Immune globulin protects non-immune contacts; vaccine available.

- **HEV**: four genotypes; **genotypes 1 and 2** cause **waterborne outbreaks** (Asia, Africa); genotype 3 is zoonotic
(**pigs**) and can become **chronic in the immunocompromised**. Liver failure and death are rare **except in pregnancy**.

## Hepatitis B: Serology and Chronicity (MSD)

*Hepatitis B markers over time, the window period, and how to read the serology panel. Drawn by TrackNation.*

- **HBV** is a **DNA** virus spread parenterally, sexually (body fluids) and from **mother to child** — babies of
infected mothers have a **70–90%** risk at delivery without HBIG and vaccine.

- Markers: **HBsAg** appears in the incubation period, **1–6 weeks before illness**, and implies infectivity;
**IgM anti-HBc** marks acute infection and fills the **window period** (HBsAg gone, anti-HBs not yet present); **anti-HBs**
appears after recovery and gives lifelong immunity; **HBeAg** suggests active replication.

- Chronicity depends on age at infection: **infants 80–90%**, children 1–5 years ~30%, **adults 1–12%**. HBV can cause
**hepatocellular carcinoma even without cirrhosis**.

- Chronic HBV: oral **tenofovir or entecavir** control but do not cure the virus; tenofovir in the third trimester for high viral loads
reduces vertical spread.

## Hepatitis C and D (MSD)

- **HCV**: RNA virus spread mainly by blood — shared needles, unsterile tattoos; sexual and vertical spread are uncommon; **no
vaccine**. Acute infection becomes **chronic in 65–85%**; cirrhosis in **15–30% over 20 years**; HCC mostly after cirrhosis.

- **Six genotypes** (genotype 1 commonest in the US). **Direct-acting antivirals** can permanently clear the virus —
pangenotypic **sofosbuvir/velpatasvir** or **glecaprevir/pibrentasvir**. Extrahepatic: **mixed cryoglobulinaemia**,
porphyria cutanea tarda; HCV recurs in liver grafts.

- **HDV** (delta agent): a **defective RNA virus** that replicates only with **HBV** — as **coinfection** with
acute hepatitis B or **superinfection** of chronic hepatitis B.

## India: Preventing Mother-to-Child HBV (NACO, UIP)

- Every pregnant woman is screened for **HBsAg** at first contact, preferably in the **first trimester** (and in labour if
unscreened).

- HBsAg-positive women are **high-risk pregnancies** delivered at centres with vaccine and **HBIG**; HBV is **not** a reason
for termination or for caesarean section; refer to **NVHCP** treatment sites.

- The newborn gets **HBIG plus the hepatitis B birth-dose vaccine** immediately after delivery; under the UIP the birth dose is given as
early as possible, **within 24 hours**.

## Traps the Examiner Sets

- In the window period HBsAg and anti-HBs are both negative — only IgM anti-HBc is positive.

- Anti-HBs alone = immunity (vaccine or recovery); HBsAg = current infection.

- The younger the age at HBV infection, the higher the chance of chronic infection.

- HEV is dangerous in pregnancy; HAV never becomes chronic.

- HDV needs HBV — preventing HBV prevents HDV.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **'Vowels hit the Bowels' — hepatitis A and E are faecal–oral** — routes

- 🧠 **'B is a DNA Boss; the rest are RNA'** — genomes

- 🧠 **Window period: 'S is gone, S-antibody not yet — Core IgM holds the Fort'** — HBV serology

- 🧠 **'The younger the host, the longer B stays' — 80–90% of infants, 1–12% of adults** — chronicity

- 🧠 **'E for Expectant mothers in danger'** — HEV

## Rapid-Revision Cards

- HAV, HEV.

- HBV, HCV (and HDV).

- RNA; no carrier; IgM anti-HAV acute.

- DNA.

- 1–6 wk before illness; infectivity.

- Only IgM anti-HBc.

- Recovery or vaccine immunity.

- Active replication.

- Infants 80–90%; adults 1–12%.

- 70–90% without prophylaxis.

- Even without cirrhosis.

- Tenofovir, entecavir (control).

- Needles; sexual/vertical rare; no vaccine.

- 65–85%; cirrhosis 15–30%/20 y.

- DAAs: sofosbuvir/velpatasvir.

- Cryoglobulinaemia, PCT.

- Needs HBV; co- or superinfection.

- G1/2 waterborne; G3 pigs.

- Pregnancy.

- Universal HBsAg in pregnancy; HBIG + vaccine.

- Birth dose within 24 h.

## Sources

*Facts in this article were checked against these documents.*

- MSD Manual Professional: Overview of Acute Viral Hepatitis; Hepatitis A; Hepatitis B (acute, chronic); Hepatitis C (acute, chronic); Hepatitis D; Hepatitis E — Merck & Co. (MSD Manuals), 2024–26 (link)

- National Guidelines for Elimination of Vertical Transmission of HIV and Syphilis (chapter 8: Hepatitis B) — National AIDS Control Organisation, MoHFW, 2024

- Universal Immunization Programme — Ministry of Health and Family Welfare, Government of India, 2026

- Competency Based Undergraduate Curriculum, Vol I: Microbiology (MI4.7–4.8) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, many of them clinical and serology scenarios.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** Hepatitis viruses spread mainly by the faecal–oral route are

- (a) C and D

- (b) B and D

- (c) B and C

- (d) A and E

**Answer: (d)** — MSD.

**Q2.** Hepatitis A

- (a) is a DNA virus

- (b) becomes chronic in 10%

- (c) has no chronic carrier state

- (d) causes HCC

**Answer: (c)** — MSD.

**Q3.** Acute hepatitis A is diagnosed by

- (a) HBsAg

- (b) HAV culture

- (c) total anti-HAV

- (d) IgM anti-HAV

**Answer: (d)** — Total = immunity.

**Q4.** Hepatitis B virus has a genome of

- (a) positive-sense RNA

- (b) DNA

- (c) defective RNA

- (d) negative-sense RNA

**Answer: (b)** — MSD.

**Q5.** The first serological marker to appear in acute HBV, before symptoms, is

- (a) anti-HBs

- (b) anti-HBe

- (c) HBsAg

- (d) IgG anti-HBc

**Answer: (c)** — 1–6 weeks before illness.

**Q6.** During the window period of acute hepatitis B, the only positive marker is

- (a) HBsAg

- (b) anti-HBs

- (c) HBeAg

- (d) IgM anti-HBc

**Answer: (d)** — MSD.

**Q7.** A vaccinated health worker who never had hepatitis B will be positive for

- (a) anti-HBs only

- (b) HBsAg

- (c) IgM anti-HBc

- (d) HBeAg

**Answer: (a)** — Anti-HBs = immunity.

**Q8.** Presence of HBeAg in an HBsAg-positive patient suggests

- (a) recovery

- (b) HDV superinfection

- (c) immunity

- (d) active viral replication and high infectivity

**Answer: (d)** — MSD.

**Q9.** The risk of chronic infection after acute HBV is highest when infection occurs in

- (a) adulthood

- (b) old age

- (c) adolescence

- (d) infancy (80–90%)

**Answer: (d)** — Adults 1–12%.

**Q10.** Without prophylaxis, a baby born to an HBV-infected mother has a risk of infection at delivery of about

- (a) 25%

- (b) 5%

- (c) 70–90%

- (d) under 1%

**Answer: (c)** — Give HBIG + vaccine.

**Q11.** Hepatocellular carcinoma can develop even without cirrhosis in

- (a) hepatitis D alone

- (b) hepatitis A

- (c) acute hepatitis E

- (d) chronic hepatitis B

**Answer: (d)** — HCV mostly after cirrhosis.

**Q12.** Chronic hepatitis B is treated with

- (a) ribavirin

- (b) interferon only as a cure

- (c) tenofovir or entecavir, which control but do not cure

- (d) sofosbuvir

**Answer: (c)** — MSD.

**Q13.** The commonest route of hepatitis C transmission is

- (a) sharing needles and other blood exposure

- (b) faecal–oral

- (c) mother to child

- (d) sexual contact

**Answer: (a)** — Sexual and vertical are uncommon.

**Q14.** The proportion of acute hepatitis C infections that become chronic is

- (a) 20%

- (b) 100%

- (c) 1–5%

- (d) 65–85%

**Answer: (d)** — MSD.

**Q15.** A vaccine is available for all EXCEPT

- (a) hepatitis A

- (b) none

- (c) hepatitis B

- (d) hepatitis C

**Answer: (d)** — No HCV vaccine.

**Q16.** Chronic hepatitis C can now be permanently cleared with

- (a) tenofovir

- (b) interferon-gamma

- (c) direct-acting antivirals such as sofosbuvir/velpatasvir

- (d) acyclovir

**Answer: (c)** — Pangenotypic.

**Q17.** An extrahepatic manifestation typical of chronic HCV is

- (a) Reye syndrome

- (b) erythema nodosum leprosum

- (c) aplastic anaemia only

- (d) mixed cryoglobulinaemia

**Answer: (d)** — Also PCT.

**Q18.** Chronic HCV leads to cirrhosis in about

- (a) 15–30% over 20 years

- (b) 50% in 1 year

- (c) 1% ever

- (d) 90% in 5 years

**Answer: (a)** — MSD.

**Q19.** Hepatitis D can replicate only in the presence of

- (a) hepatitis C virus

- (b) HIV

- (c) hepatitis A virus

- (d) hepatitis B virus

**Answer: (d)** — Defective RNA.

**Q20.** HDV infecting a person who already has chronic hepatitis B is called

- (a) seroconversion

- (b) reactivation

- (c) superinfection

- (d) coinfection

**Answer: (c)** — Coinfection = with acute HBV.

**Q21.** Waterborne epidemics of hepatitis in India and Asia are typically due to

- (a) HDV

- (b) HAV only

- (c) HCV

- (d) HEV genotypes 1 and 2

**Answer: (d)** — Faecal contamination of water.

**Q22.** Hepatitis E is especially dangerous in

- (a) vaccinated adults

- (b) smokers

- (c) children under 5

- (d) pregnancy

**Answer: (d)** — MSD.

**Q23.** The main animal reservoir of zoonotic HEV is the

- (a) bat

- (b) rat

- (c) pig

- (d) monkey

**Answer: (c)** — Genotype 3.

**Q24.** Chronic hepatitis E has been reported in

- (a) children only

- (b) immunocompromised patients such as transplant recipients

- (c) never

- (d) all pregnant women

**Answer: (b)** — Genotype 3.

**Q25.** Under NACO's EVTHS guidelines, HBsAg screening in pregnancy is

- (a) only in labour

- (b) only for high-risk women

- (c) universal, preferably in the first trimester

- (d) not recommended

**Answer: (c)** — NACO 2024.

**Q26.** An HBsAg-positive pregnant woman should be

- (a) given hepatitis B vaccine for herself

- (b) managed as a high-risk pregnancy with delivery where HBIG and vaccine are available

- (c) delivered by caesarean routinely

- (d) offered termination

**Answer: (b)** — NACO.

**Q27.** The newborn of an HBsAg-positive mother should receive

- (a) nothing until tested

- (b) vaccine at 6 weeks only

- (c) HBIG alone

- (d) HBIG plus hepatitis B vaccine immediately after delivery

**Answer: (d)** — NACO.

**Q28.** Under India's UIP, the hepatitis B birth dose is given

- (a) at 6 weeks

- (b) at 9 months

- (c) only to high-risk babies

- (d) as early as possible, within 24 hours

**Answer: (d)** — UIP 2026.

**Q29.** The commonest mode of hepatitis B spread emphasised in NACO counselling is

- (a) mosquitoes

- (b) mother to newborn

- (c) casual contact

- (d) food

**Answer: (b)** — NACO.

**Q30.** Non-immune household contacts of a patient with hepatitis A can be protected by

- (a) HBIG

- (b) standard immune globulin (or vaccine)

- (c) nothing works

- (d) acyclovir

**Answer: (b)** — MSD.

### Active Recall

From memory: give the genome, route and chronicity of hepatitis A to E, explain the HBV serological markers and window period, state chronicity by age and cancer risk, outline HCV genotypes and treatment, distinguish HDV coinfection from superinfection, describe HEV, and state India's HBV screening and newborn prophylaxis policy.
